[ad_1]
Denmark has decided not to apply Johnson & Johnson’s vaccine in its coronavirus vaccination campaign for possible “unwanted effects” that it can cause, after cases of patients who were inoculated with this formula and then presented venous cerebral thrombus. For the same reason, the country ruled out the use of the AstraZeneca vaccine in April, which was also associated with the appearance of thrombi.
“The benefits of using the Johnson & Johnson Covid-19 vaccine do not outweigh the risk of causing a possible side effect”the Danish National Health Authority said on Monday, referring to a very rare type of venous thrombosis.
Therefore, he continued, country to continue mass vaccination program “without the Johnson & Johnson vaccine”, despite the authorization of the World Health Organization (WHO) and the European Medicines Agency (EMA), which have ensured that the balance between benefit and risk remains “positive”.
The country had not even authorized the drug marketed in Europe by Janssen, a subsidiary of the American pharmaceutical company, although it did. ordered 8.2 million doses of this vaccine, pending the results of an assessment started in April.
Denmark thus becomes one of the first countries in the world to renounce the use of the Johnson & Johnson vaccine, administered in 17 countries, including Spain, the United States and France. Last April, it had already become the first country to discontinue use of the AstaZeneca formula, which has also been linked to the formation, although very rare, of blood clots.
Currently only Four vaccines are authorized in the European Union: Pfizer / BioNTech, Moderna, AstraZeneca and Johnson & Johnson, but with age limits for the latter two.
The decision not to apply the Johnson & Johnson formula, will slow down the current vaccination campaign in Denmark by four weeks, where the pandemic is considered “under control”, the majority of people at risk and health workers having already been vaccinated.
According to a latest report, 11.5% of 5.8 million Danes were fully vaccinated and 23.4% received a first dose.
.
[ad_2]
Source link